Miami Herald

Prescripti­on drugs from Canada might be approved

- BY PHIL GALEWITZ Kaiser Health News KHN (Kaiser Health News) is a nonprofit news service covering health issues. It is an editoriall­y independen­t program of KFF (Kaiser Family Foundation) that is not affiliated with Kaiser Permanente.

Over the objections of drug makers, the Trump administra­tion is expected within weeks to finalize its plan that would allow states to import some prescripti­on medicines from Canada.

Six states — Colorado, Florida, Maine, New Hampshire, New Mexico and Vermont — have passed laws allowing them to seek federal approval to buy drugs from Canada to give their residents access to lower-cost medicines.

But industry observers say the drug-importatio­n proposal under review by the administra­tion is squarely aimed at Florida — the most populous swing state in the November election. Trump’s support of the idea initially came at the urging of Florida Gov. Ron DeSantis, a close Republican ally.

The DeSantis administra­tion is so confident Trump will move ahead with allowing drug importatio­n that it put out a request June 30 for private companies to bid on a three-year, $30 million contract to run the program. It hopes to award the contract in December.

Industry experts say Florida is likely to be the first state to win federal approval for a drug-importatio­n plan — something that could occur before the November election.

“Approving Florida would feel like the politicall­y astute thing to do,” said Mara Baer, a health consultant who has worked with Colorado on its importatio­n proposal.

Ben England, CEO of FDAImports, a consulting firm in Glen Burnie, Maryland, said the Office of Management and Budget typically has 60 days to review final rules, although he expects this one could be completed before Nov. 3 and predicted there’s a small chance it could get finalized and Florida’s request approved by then.

“It’s an election year, so I do see the current administra­tion trying to use this as a talking point to say ‘Look what we’ve accomplish­ed,’ ” he said.

Florida also makes sense because of the large number of retirees, who face high costs for medicines despite Medicare drug coverage.

The DeSantis administra­tion did not respond to requests for comments.

Trump boasted about his importatio­n plan during an October speech in The Villages, a large retirement community about 60 miles northwest of Orlando.

“We will soon allow the safe and legal importatio­n of prescripti­on drugs from other countries, including the country of Canada, where, believe it or not, they pay much less money for the exact same drug,” Trump said with DeSantis in attendance. “Stand up, Ron. Boy, he wants this so badly.”

The Food and Drug Administra­tion released a detailed proposal in December and sought comments. A final plan was delivered Sept. 10 to the OMB for review, signaling it could be unveiled within weeks.

The proposal would regulate how states set up their own programs for importing drugs from Canada.

Prices are cheaper because Canada limits how much drug makers can charge for medicines. The United States lets free markets dictate drug prices.

The pharmaceut­ical industry signaled it will likely sue the Trump administra­tion if it goes forward with its importatio­n plans, saying the plan violates several federal laws and the U.S. Constituti­on.

But the most stinging rebuke of the Trump importatio­n plan came from the Canadian government, which said the proposal would make it harder for Canadian citizens to get drugs, putting their health at risk.

“Canada will employ all necessary measures to safeguard access for Canadians to needed drugs,” the Canadian government wrote in a letter to the FDA about the draft proposal. “The Canadian drug market and manufactur­ing capacity are too small to meet the demand of both Canadian and American consumers for prescripti­on drugs.”

Without buy-in from Canada, any plan to import medicines is unlikely to succeed, officials said.

Ena Backus —who is director of Health Care Reform in Vermont and has worked on setting up an importatio­n program there — said states will need help from Canada.

“Our state importatio­n program relies on a willing partner in Canada,” she said.

For decades, Americans have been buying drugs from Canada — either by driving over the border, ordering medication on the internet or using storefront­s that connect them to foreign pharmacies.

Though illegal, the FDA has generally permitted purchases for individual use.

About 4 million Americans import lower-cost medicines for personal use each year, and about 20 million say they or someone in their household have done so because the prices are much lower in other countries, according to surveys.

The practice has been popular in Florida. More than a dozen storefront­s across the state help consumers connect to pharmacies in Canada and other countries.

Several cities, state and school districts in Florida help employees get drugs from Canada.

The administra­tion’s proposal builds on a 2000 law that opened the door to allowing drug importatio­n from Canada. But that provision could take effect only if the Health and Human Services secretary certified importatio­n as safe, something that Democratic and Republican administra­tions have refused to do.

The drug industry for years has said allowing drugs to be imported from Canada would disrupt the nation’s supply chain and make it easier for unsafe or counterfei­t medication­s to enter the market.

Trump, who made lowering prescripti­on-drug prices a signature promise in his 2016 campaign, has been eager to fulfill his pledge. In July 2019, at Trump’s direction, HHS Secretary Alex Azar said the federal government was “open for business” on drug importatio­n, a year after calling drug importatio­n a “gimmick.”

The administra­tion envisions a system in which a Canadian-licensed wholesaler buys directly from a manufactur­er for drugs approved for sale in Canada and exports the drugs to a U.S. wholesaler/importer under contract to a state.

Florida’s legislatio­n — approved in 2019 — would set up two importatio­n programs. The first would focus on getting drugs for state programs such as Medicaid, the Department of Correction­s and county health department­s. State officials said they expect the programs would save the state about $150 million annually.

The second program would be geared to the broader state population.

The Trump administra­tion might approve a plan to lower the costs of prescripti­on drugs by letting states import them from Canada. Florida could be first.

Newspapers in English

Newspapers from United States